To uncover the association between Nur77 expression and cancer, we surveyed Nur77 expression levels in 34 kinds of tumors, which indicated a significantly downregulated expression in the major kinds of tumors, including PRAD (Figure 1A,B). Here, NR4A1 is linked to prostate adenocarcinoma.